Moderna plans to be added to the Nasdaq October 9 Index before the market opens 100 Index

AT A GLANCE

above the current price. BlockBeats stated that Moderna will be added to the Nasdaq 100 and disclosed MRNA price data and position data for long holders.

Article

Moderna to be added to the Nasdaq index today 100, with highly profitable accounts expecting the share price to rise further 70%

BlockBeats reports that October 9，October 9，Moderna will, tonight Beijing time (October 9）21: 30 be officially added to the Nasdaq 100 Index before the U.S. stock market opens, replacing Warner Bros. Discovery. This adjustment was announced on October 1.

From the U.S. stock market close before the announcement on October 1 to the latest close on October 8,MRNA the share price rose from 188.94 USD to 197 USD, a cumulative increase of approximately 4.27%

Moderna is a U.S. biotechnology company that develops vaccines and medicines using mRNA technology, with R&D spanning infectious diseases, cancer, and rare diseases. In addition to its vaccine business, the company's personalized mRNA cancer therapy, developed in collaboration with Merck, announced positive Phase trial results on August, achieving the primary endpoint of recurrence-free survival in adjuvant melanoma treatment, a key catalyst for the share price.

Recently, a suspected pneumonic plague incident in Russia has also drawn attention to vaccine stocks, with Moderna rising by approximately October 5 on 6.95%. However, as of the latest public information, the pathogen involved in the incident has not yet been WHO confirmed; Russian authorities said tests of contacts found no plague, while the European Centre for Disease Prevention and Control also stated that there is no evidence of sustained human-to-human transmission.

According to TradingBeats monitoring, the MRNA on-chain contract is quoted at 196.45 USD，24, up approximately 0.56%over hours; open interest is approximately 15600 contracts, with a notional value of approximately 3059000 USD；24; approximately 43500 contracts were traded over hours, with trading volume of approximately 8521000 USD。

. The largest long holders collectively hold approximately 448500 USD in long positions, with unrealized profit of approximately 61500 USD：

- Largest long holder: approximately 242500 USD in long positions. Holding 3 contracts with 1233.05 x leverage, at an average price of 175.78 USD, unrealized profit is approximately 25800 USD, with a return of approximately 35.7%and a liquidation price of 124.15 USD（0x9a37…）。

- Second-largest long holder: approximately 205900 USD in long positions. Holding 10 contracts with 1046.98 x leverage, at an average price of 162.58 USD, unrealized profit is approximately 35700 USD, with a return of approximately 209.8%and a liquidation price of 154.69 USD（0x599d…）。

The second-largest long holder placed a market take-profit trigger order at 350 USD covering all existing positions, approximately 77.9%。

Key points

The original text stated that Moderna will be officially added to the Nasdaq October 9 Index before the U.S. stock market opens on 21: 30 Beijing time, replacing Warner Bros. Discovery. 100 Index, replacing Warner Bros. Discovery.
The original text stated that this index adjustment was announced on October 1.
The original text stated that the share price rose from MRNA at the close on October 1 to 188.94 USD at the close on October 8, a cumulative increase of approximately 197 USD, a cumulative increase of approximately 4.27%。
The original text stated that Moderna is a U.S. biotechnology company developing vaccines and medicines using mRNA technology.
The original text stated that Moderna's personalized mRNA cancer therapy, developed in collaboration with Merck, announced positive Phase trial results on August.
The original text stated that, as of the latest public information, the pathogen involved in the suspected pneumonic plague incident in Russia has not yet been WHO confirmed; Russian authorities said tests of contacts found no plague, and the European Centre for Disease Prevention and Control stated that there is no evidence of sustained human-to-human transmission.
According to TradingBeats monitoring cited by the original text, the MRNA on-chain contract is quoted at 196.45 USD，24, up approximately 0.56%。
over hours. The original text stated that the largest long holders collectively hold approximately 448500 USD in long positions, with unrealized profit of approximately 61500 USD。
The original text stated that the second-largest long holder placed a market take-profit trigger order at 350 USD covering all existing positions, approximately 77.9%。

AI-assisted interpretation

The following is analysis, separate from reported facts. Verify important claims independently.

This article primarily discusses matters: first,Moderna is reportedly to be added to the Nasdaq 100 Index; second, the positions and take-profit settings of relatively large long holders in the on-chain contract market. “Inclusion in an index” means that the stock becomes a constituent of that index. Long positions indicate that traders are betting on a price increase, but a take-profit trigger price is merely a sell condition set by a trader and does not mean that the share price will necessarily reach that price.

Why it matters to readers

Index constituent adjustments, company trial results, and public-health events may all increase market attention on MRNA. The price, trading, and leveraged-position data listed in the original text also reflect related trading activity and some traders' bullish bets.

Beginners should distinguish between price movements that have already occurred, future index adjustments reported by the media, and individual accounts’ trading expectations. Highly leveraged positions may generate substantial profits, but may also incur losses as a price decline brings them close to the liquidation price.

Risks and unknowns

The material provides only a BlockBeats report and does not include an announcement from Nasdaq, so it is not possible to independently confirm whether the index adjustment took effect at the stated time.
At the time described in the original text, the pathogen responsible for the suspected pneumonic plague incident in Russia had not yet been WHO confirmed.

Moderna plans to be added to the Nasdaq October 9 Index before the market opens 100 Index

Article

AI-assisted interpretation

Why it matters to readers

Risks and unknowns

Related Developments

Related concepts

Keep following

Security Center